
Minerva suffers another CNS defeat; Eli Lilly wins OK for tau-based Alzheimer's diagnostic
→ Months after a depressing end to Minerva Neurosciences‘ quest to develop a depression drug, the Waltham, Massachusetts-based drug developer unveiled more bad news …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.